United States
Health Care
Medical
Education
Reduce the risk of bloodstream infections

Medical

Three keys to reducing bloodstream infection risk

At 3M, we believe protecting patients by sustaining zero IV complications is a goal every facility should have. And we want to do everything in our power to help you achieve it. So we’ve set a bold goal -- zero bloodstream infections.

We believe there are three keys to reaching this goal: people, standards, and technology. It’s an effort that requires exacting standards of care, a commitment from the care team to methodically adhere to those standards, and technology that adds an additional layer of antimicrobial protection.

Help reduce the risk of bloodstream infections at all access points.

EXPLORE 3M SOLUTIONS

Intravenous therapy is often the first critical intervention into a patient's body. While it is common, it is not without risk. Catheter-associated bloodstream infections (CABSIs) can be acquired at the time of the initial insertion or anytime throughout the duration of intravenous access — creating the potential for longer hospital stays¹⁻⁵, increased care costs²’⁷ and higher patient mortality⁶. Incorporating evidence-based standards to infusion therapy can help protect against the factors that may lead to increased risk of bloodstream infection.

60% of all CABSIs originate from some form of vascular access.⁵
1 in 4 patients who contract a CABSI will die.⁶
The cost to treat one CABSI averaged $45,000 USD per patient.³’⁷

Healthcare professional setting out catheter parts on a table

Best practices for Infusion Therapy.

The Infusion Nurses Society (INS) is a global authority on infusion therapy, setting stringent standards for practice. Every five years, INS releases updated, peer-reviewed standards that reflect the latest evidence to define and develop best practices for all clinical settings. 3M can help you stay up to date so you can help deliver better patient outcomes.

SEE SELECT HIGHLIGHTS

We can help you meet current guidelines with evidence-based solutions.

Protecting patients from CABSIs requires a commitment from the care team to methodically adhere to evidence-based standards established by well-regarded organizations such as INS, SHEA, APIC and CDC.

3M partners with you, offering a portfolio of innovative solutions to help you protect every IV catheter site — from insertion to removal — every time. From hand hygiene and skin protectant to securement devices, disinfecting caps and more, our evidence-based products can help you deliver compassionate care, protect patients, help prevent the risks of costly complications, and improve patient satisfaction.

Need more information? Connect with 3M.

3M Solutions align with current best practice standards

3M™ Tegaderm™ I.V. Advanced Securement Dressings

Health Care Professional in ICU with a patient

Comprehensive Infection Prevention

3M takes a holistic approach to help you identify and reduce infection and transmission risks, navigate rapidly changing standards and guidelines, and provide science-based solutions that can help you protect patients, staff and everyone who enters your facility.

LEARN MORE ON INFECTION PREVENTION

3M resources to help you stay informed.

3M™ Health Care Academy

3M™ Health Care Academy offers free, quality educational content in a flexible online format. Choose from more than 50 CE credit courses to support your professional development.
Read our Blog: Transforming Outcomes

Insights on skin, complications prevention and patient care.
3M™ Peak™ Clinical Outcomes Program

The 3M™ Peak™ Clinical Outcomes Program provides you with the resources and partnership you need to define and achieve outcomes.
3M™ Vascular Access Solutions: How to use resources

Resources to help you learn how to use the vascular access products that your facility uses.

Patient Stories

1. Maki D, Mermel L: Infections due to infusion therapy. In Hospital Infections, edn 4.Edited by Bennett JV, Brachman PS. Philadelphia: Lippincott-Raven; 1998:689–724.
2. CDC Vital Signs: Making health care safer: Reducing bloodstream infections. Centers for Disease Control and Prevention website. https://www.cdc.gov/vitalsigns/pdf/2011-03-vitalsigns.pdf (PDF, 2.75 MB) Published March, 2011. Accessed June 18, 2017.
3. Blot SI, Depuydt P, Annemans L, Benoit D, Hoste E, De Waele JJ, Decruyenaere J, Vogelaers D, Colardyn F, Vandewoude KH. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis. 2005 Dec 1;41(11):1591-1598
4. Zimlichman E, Henderson D, et al. Health Care–Associated Infections: A Meta-analysis of Costs and Financial Impact on the US Health Care System. JAMA Intern Med. 2013 Dec 9-23;173(22):2039-2046. doi: 10.1001/ jamainternmed.2013.9763
5. Scheithauer S, Lewalter K, Schröder J, et al. Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing. Infection. 2014;42(1):155-9
6. Center for Disease Control (2005). Vital Signs: Making Health Care Safer. Accessed 7/29/2019 https://www.cdc.gov/vitalsigns/pdf/2011-03-vitalsigns.pdf (PDF, 2.75 MB)
7. Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: A meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039-2046